Moderna begins studying potential COVID-19 vaccine booster targetting variant first detected in South Africa February 24, 2021 Drug manufacturer Moderna says it will begin testing a variant-specific version of its COVID-19 vaccine that would target the B1351 variant first detected in South Africa. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.